News Coverage 11.13.19 By: Marta Figueiredo Share on Twitter Share on Facebook Share on LinkedIn CRISPR-edited T-cells Safely, Effectively Target Cancer Cells in Myeloma Patients, Early Phase 1 Data Suggests Related Announcement, Press Release Parker Institute for Cancer Immunotherapy Names Maria Olson Chief Advancement Officer Announcement, Press Release PICI Invests $1 Million+ in 5 Early Career Researchers Announcement, Patient Story Living Proof: Cancer Vaccine Recipients Bring Their Sto
Announcement, Press Release Parker Institute for Cancer Immunotherapy Names Maria Olson Chief Advancement Officer